Redose
Ozempic and Wegovy come from the same maker and the same molecule, semaglutide, yet a prescriber reaches for them in different situations. Ozempic for type 2 diabetes is the older approval, cleared in 2017 to lower blood sugar. Wegovy arrived in 2021 for weight management, at a higher weekly dose. Same active drug, two labels.
So the real difference between ozempic and wegovy is not the ingredient. It is the approved use, the top dose, and the monthly price. Both are made by Novo Nordisk and both are once-weekly injections you give yourself under the skin. This piece reports what the labels and published trials say, and Redose is for tracking and record-keeping only, so leave the prescribing decisions to your clinician.
Ozempic for type 2 diabetes came first
Ozempic is approved to improve blood sugar in adults with type 2 diabetes, and its label also covers lowering the risk of major cardiovascular events in people who have type 2 diabetes and known heart disease. It is not approved for weight loss, though clinicians do prescribe it off label. The weekly dose tops out at 2 mg.
The pen climbs in steps. You start at 0.25 mg for four weeks, a starter dose meant to settle the stomach rather than treat anything, then move to 0.5 mg. From there a prescriber can raise you to 1 mg and, if needed, to the 2 mg ceiling, holding each step at least four weeks.
- Weeks 1 to 4: 0.25 mg to ease side effects
- Weeks 5 to 8: step up to 0.5 mg weekly
- Then 1 mg weekly if more control is needed
- Ceiling of 2 mg weekly for type 2 diabetes
Ozempic and Wegovy are the same molecule. The label, not the ingredient, decides which one a prescriber writes.
The Wegovy dosage chart climbs higher
Wegovy is approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or sleep apnea. In 2024 its label added a cardiovascular indication as well. The maintenance dose is 2.4 mg weekly, higher than the Ozempic ceiling.
The wegovy dosage chart adds a rung the diabetes ladder does not have. It runs 0.25, 0.5, 1, then 1.7, then 2.4 mg, again with about four weeks at each step. That slow climb is how the higher dose stays tolerable, since nausea tends to track with how fast you escalate.
| Weeks | Ozempic | Wegovy |
|---|---|---|
| 1 to 4 | 0.25 mg | 0.25 mg |
| 5 to 8 | 0.5 mg | 0.5 mg |
| 9 to 12 | 1 mg | 1 mg |
| 13 to 16 | 2 mg max | 1.7 mg |
| 17 plus | 2 mg | 2.4 mg |
What the weight loss trials measured
The clearest data on semaglutide for weight loss comes from the STEP 1 trial. Over 68 weeks, adults on the 2.4 mg Wegovy dose lost 14.9% of their body weight on average, against 2.4% for placebo, across 1,961 participants. That is the number behind the weight management approval.
Ozempic's diabetes trials, the SUSTAIN program, were built to measure blood sugar first, and weight came second. People did lose weight, but the 2 mg diabetes ceiling sits below the 2.4 mg weight dose, so the average loss reported for ozempic for weight loss tends to land under what the Wegovy trials showed.
In STEP 1, 68 weeks on Wegovy 2.4 mg produced a mean 14.9% drop in body weight, versus 2.4% on placebo.
Do the semaglutide weight loss injections differ in strength?
Both are semaglutide weight loss injections in a prefilled pen, but strength and schedule differ. Wegovy reaches 2.4 mg; the Ozempic pen stops at 2 mg. A single milligram sounds small, yet at these doses it shifts both the average result and the side-effect load a person carries.
What Ozempic and Wegovy cost each month
Price is where the difference between the two gets concrete. Ozempic carries a list price near 1,027 dollars a pen, and Wegovy lists at 1,349 dollars for a 28-day supply. Almost nobody with coverage pays the full sticker, but the list price still drives copays and cash prices.
In late 2025 Novo Nordisk cut cash prices, offering both Wegovy and Ozempic at 349 dollars a month through its NovoCare pharmacy, with the first two starter doses at 199 dollars each into early 2026. Insurance for a diabetes prescription often lands lower than a cash weight plan.
- Ozempic list price near 1,027 dollars a pen
- Wegovy list price near 1,349 dollars a month
- NovoCare cash price of 349 dollars a month
- Starter doses at 199 dollars into early 2026
Where compounded semaglutide fits
During the 2022 to 2024 shortage, telehealth clinics sold compounded semaglutide well below the brand price. The FDA has since declared the shortage resolved, which narrows who can legally compound it. Compounded semaglutide is not an FDA-approved product and dose accuracy can vary, so it is worth asking a prescriber before you trust a chart to it.
Half-life, missed doses, and keeping a clean log
Semaglutide has a long half-life, roughly seven days, which is why one injection a week works and why a late dose is not an emergency. Both products share that pharmacology because they share the molecule. Steady logging matters more than perfect timing.
The missed-dose rules split by product. For Ozempic you can take a late dose within five days, then return to your usual day. For Wegovy, take it only if your next dose is more than two days away, otherwise skip it, per the missed-dose guidance. Neither label lets you double up to catch up.
A seven-day half-life means a dose you take today is still working next week. Never double up to make up a miss.
- Ozempic: take a late dose within five days
- Wegovy: skip if next dose is under two days
- Never take two doses to cover a missed one
- Log the date, dose, and site every week
This is the record-keeping that a calculator and a log make easy. Enter your vial size and bacteriostatic water into the dose calculator to get exact syringe units, then log each shot and rotate injection sites on the body map. New to mixing a vial? Start with our reconstitution guide, then see how to read your syringe in units and the full semaglutide dosage chart.
Common questions about Ozempic and Wegovy
Is Ozempic and Wegovy the same?
They share one active ingredient, semaglutide, and one maker, so chemically they are the same drug. They are not the same product. The approved use and the top dose differ, which is why the question is ozempic vs wegovy and not one label serving both needs.
What is the difference between Ozempic and Wegovy?
Ozempic is approved for type 2 diabetes and tops out at 2 mg a week. Wegovy is approved for weight management and climbs to 2.4 mg. Framed as wegovy vs ozempic, the weight drug carries the higher dose and the weight-management label, nothing more exotic than that.
Can you take Ozempic for weight loss?
Some clinicians prescribe ozempic for weight loss off label, but it is approved only for diabetes, and the 2 mg ceiling is lower than Wegovy's. Coverage and supply often decide which one a person actually gets. Your prescriber weighs that, not a blog post.
Which is stronger for weight loss, Wegovy or Ozempic?
At the top of each ladder, Wegovy's 2.4 mg is the higher dose and the one studied for weight, so the wegovy for weight loss data is stronger. Ozempic can help, but its trials centered on blood sugar. Neither should be started or changed without medical guidance.
Whether your prescriber writes Ozempic for type 2 diabetes or Wegovy for weight management, the tracking is the same weekly rhythm. Redose turns your vial size into exact syringe units, sends gentle reminders, rotates your injection sites, and keeps a private log of every dose and side effect. Get the app here: iOS.